• 32nd Nikolas Symposium 2024

Tissue inflammation and the Langerhans cell histiocytosis lesion

• 31th Nikolas Symposium 2023

Eradicating the neoplastic clone

• 30th Nikolas Symposium 2022

Neurodegeneration in LCH

• 29th Nikolas Symposium 2019

Immune Strategies in the Histiocytoses

• 28th Nikolas Symposium 2018

Myeloid Cell Programming and Differentiation

• 27th Nikolas Symposium 2017

LCH: The Cell of Origin and a Pathway to a Rationale Cure

• 26th Nikolas Symposium 2016

Mechanisms of Resistance and Therapeutic Development

• 25th Nikolas Symposium 2015

Mechanisms and Long term Consequences of Neuroinflammatory Disease

• 24th Nikolas Symposium 2014

Harnessing Immunology and Inflammation in Neoplasms: Relevance to LCH and Histiocytic Disorders

• 23rd Nikolas Symposium 2013

Cellular Origins  of Dendritic  CelΙs: Implications  for LCH

• 22nd Nikolas Symposium 2012

Cell Signaling and Responses: Pathways to Cure?

• 21st Nikolas Symposium 2011

Genomics and Metabolomics in Dendritic Cells: Are there clues for LCH causes and cures?

• 20th Nikolas Symposium 2010

Mechanisms and therapeutic targets of inflammatory disease of the CNS

• 19th Nikolas Symposium 2009

Viral, autoimmune and neoplastic mechanisms of granuloma formation and possible relevance to LCH

• 18th Nikolas Symposium 2008

The tolerogenic nature of tumor-associated inflammation: relevance for LCH

• 17th Nikolas Symposium 2007

Langerhans Cell Function: Implications for LCH

• 16th Nikolas Symposium 2006

A hematopoietic stem cell disorder?

• 15th Nikolas Symposium 2005

Dendritic cell plasticity

• 14th  Nikolas Symposium 2004

Langerhans cell histiocytosis: Bystander cells, interactions, pathophysiology

• 13th Nikolas Symposium 2003

Langerhans cell histiocytosis: neoplasia or immune dysregulation?

Proceedings by Dr Kim Nichols: Click Here.

• 12th  Nikolas Symposium 2002

Dendritic cell differentiation: Signals, signalling and functional consequences: Clues to possible therapy.

Analysis of the functional consequences of aberrant antigen expression.

• 11th Nikolas Symposium 2001

Acute and chronic cytokine networks leading to tissue damage.

• 10th Nikolas Symposium 1999

Dendritic cells and the brain in LCH.

• 9th Nikolas Symposium 1998

Genetics and animal models of Langerhans Cell Histiocytosis (LCH). Identified the need for animal models

• 8th Nikolas Symposium 1997

Migration and in vivo interactions of immune cells. Led to work on chemokines

• 7th Nikolas Symposium 1996

Apoptosis in LCH. Stimulated work on the cell cycle and survival

• 6th Nikolas Symposium 1995

Cell biology and molecular biology in LCH. Discussed dendritic-cell differentiation and cell survival and death.

• 5th Nikolas Symposium 1993

Langerhans cell histiocytosis therapeutics present and future. Stimulated use of antibodies for localization and treatment of disease

• 4th Nikolas Symposium 1992

The neuropathology and pharmacology of LCH. Led to long-term studies of neurological and psychosocial aspects of the disease

• 3rd Nikolas Symposium 1991

The role of cytokines in LCH. Stimulated much work on cytokines

• 2nd Nikolas Symposium 1990

Viruses as a possible trigger in LCH – developing a strategy. No evidence for viral aetiology

• 1st  Nikolas Symposium 1989

LCH – an immunological disease? Identified avenues for future research and the importance of determining clonality